When a venture investor writes a check, they don't buy common stock. They buy convertible preferred stock — a security with rights, preferences, and protections that common shareholders don't have. The term sheet is the document where those rights get specified. This module walks through what's in a term sheet, why each provision exists, and how to read the document without being misled by the headline valuation.
Common stock is what founders and employees hold. It is the simplest equity security: each share entitles its holder to a proportional share of dividends (when paid) and of exit proceeds (when realized). Debt is what banks lend: a fixed obligation to pay back principal and interest, with no upside beyond that. Venture investors deliberately use neither.
Instead, they buy convertible preferred stock — a security that sits between common equity and debt in the capital structure. Preferred stock has rights and protections that common doesn't have, but unlike debt, it has full participation in the upside if the company succeeds. The structural design solves a specific problem the venture investor faces.
A venture investor putting $10M into a company at a $50M post-money valuation is betting on a high-uncertainty outcome. In the upside case — the company is worth $1B at exit — they want their full 20% share of the proceeds ($200M). In the downside case — the company is sold for $30M — they want their $10M back rather than just 20% of the proceeds ($6M). Common stock gives them the first behavior but not the second. Debt gives them the second but not the first. Preferred stock with a liquidation preference and a conversion option gives them both.
The mechanism: preferred stock has a "liquidation preference" — typically the right to get the original investment back before common shareholders receive anything — combined with a "conversion right" — the option to convert into common stock at exit if that produces a better outcome. The investor takes the better of the two paths.
In a downside outcome where the sale price is barely above the preference amount, the preference dominates and the investor takes their money back. In an upside outcome where the company is worth far more than the preference would pay, the investor converts to common and takes their pro-rata share of the proceeds. This is the optionality structure that makes preferred stock the standard venture instrument.
From the founder's perspective, the same mechanism explains why founders can take home nothing in a modest exit (as the Pipework example in Module 03 showed). The preferences come out first. Only after all preferred shareholders have been paid does common stock — held by founders and employees — receive anything.
A term sheet is the document the investor signs that describes the proposed financing. It's not the final legal documents — those come later, in 50–100 pages of "definitive documents" (the Stock Purchase Agreement, the Investor Rights Agreement, the Voting Agreement, and the amended Certificate of Incorporation). The term sheet is the 5–10 page summary that the parties negotiate before the lawyers turn the agreement into final documents. It is mostly non-binding, but the terms in it are what end up in the definitive documents.
Every term sheet has two halves, and one of the most common mistakes first-time founders make is over-focusing on the first half while under-focusing on the second:
| Economic terms | Control terms |
|---|---|
| Valuation (pre- vs post-money) | Board composition |
| Liquidation preference | Protective provisions |
| Participation rights | Drag-along rights |
| Anti-dilution protection | Founder vesting |
| Option pool | Information rights |
| Pro-rata rights | Right of first refusal / co-sale |
| No-shop provision | Dividends |
The next two sections walk through each side. The split matters because economic terms determine "how much of the company the investor gets," while control terms determine "what the investor can make the company do." A founder who optimizes only for economic terms can lose effective control of the company even while retaining a large equity stake.
The economic terms determine the financial flows: how much the investor pays, what they get, what happens to them on exit, and how they are protected against later down rounds.
The "pre-money" valuation is what the company is worth before the new investment. The "post-money" is the pre-money plus the new investment. A $5M investment at a $20M pre-money creates a $25M post-money valuation, with the investor owning $5M ÷ $25M = 20% of the company. The distinction matters because "valuation" without qualification is ambiguous — investors typically quote pre-money, founders typically think in post-money, and confusion at this layer can produce 5-10% ownership swings.
The liquidation preference is the amount the preferred shareholder receives before common shareholders receive anything. 1× non-participating is the standard: the investor gets the greater of (a) their original investment back, or (b) their pro-rata share of proceeds — but not both. 1× participating is more aggressive: the investor gets their original investment back and their pro-rata share — they "double-dip." 2× preference means they get twice their original investment back before common sees anything. Each of these gets meaningfully worse for founders.
In the 2021 boom, founders successfully pushed back on participating preferred to the point where it became unusual. In the 2022-23 downturn, participating preferred returned in many late-stage deals as investors regained leverage. The 2026 norm has settled back toward 1× non-participating for early stages, with mixed practice at later stages.
Anti-dilution protection compensates existing preferred investors if a future round prices the company below their entry price (a "down round"). The two main mechanisms differ wildly in their effect on founders. Weighted-average protection adjusts the conversion price modestly to reflect the new lower price, with the size of adjustment weighted by the size of the new round. It's the standard and is widely viewed as reasonable. Full ratchet adjusts the conversion price all the way down to the new round's price, regardless of round size. Full ratchet can convert a moderate down round into a catastrophic dilution event for founders and employees.
The Klarna 2022 down round (which we covered in Module 02) saw the company's valuation cut by 85%. The anti-dilution math that played out — under whatever protections the earlier rounds had — significantly affected the post-down-round cap table. Module 09 will work through the mechanics. For now: anti-dilution protection matters, weighted-average broad-based is the standard, and full ratchet should be resisted by founders unless they're in desperate need of capital.
Most term sheets require the company to set up or expand an option pool before the round closes, with the pool sized to last until the next financing. The mechanical subtlety: the option pool is calculated pre-money, which means it dilutes the existing shareholders (founders, earlier investors) rather than the new investor. A "20% post-money" Series A that includes setting up a 12% pre-money option pool effectively dilutes the founders by ~12% before the new investor's 20% even comes in. The combined dilution is closer to 32%.
This is the "option pool shuffle" mentioned in Module 02. It's not necessarily abusive — option pools really are needed, and they really do dilute someone — but founders should understand what they're agreeing to and push back when the requested pool seems oversized for the company's actual needs through the next round.
Pro-rata rights give the existing investor the option (not obligation) to invest in subsequent rounds at the same percentage they currently hold. A seed investor with 15% of the company and pro-rata rights can buy 15% of any future round, maintaining their ownership level. This is mostly reasonable — existing investors who believe in the company should be able to keep their ownership level — but it's worth tracking because the cumulative pro-rata of all earlier rounds can use up a large fraction of a later round's available capacity, sometimes crowding out new strategic investors.
The no-shop provision is the agreement that, once the term sheet is signed, the company will not actively pursue alternative financings while the investor completes due diligence. It's reasonable in principle — investors don't want to spend weeks on diligence only to be used as a stalking horse — but the period should be limited, and the founder should retain the ability to respond to unsolicited offers. Long no-shop provisions are an underrated source of risk: if the round falls apart after 60 days of exclusivity, the company has burned two months of runway and lost its negotiating position with other investors.
The control terms are where the founder's day-to-day reality gets shaped. Economic terms determine who gets what at exit; control terms determine what the company can and cannot do between now and exit. Most experienced investors and founders pay more attention to control terms than to economic terms.
The board hires and fires the CEO, approves major strategic decisions, sets compensation, and signs off on financings and acquisitions. Board composition determines who controls these decisions. A typical Series A board has the founders and the lead investor as voting members, possibly with an independent director the parties agree on. The arithmetic is what matters: in a 3-person board with 2 founders and 1 investor, the founders still have voting majority. In a 5-person board with 2 founders, 2 investors, and 1 independent, the founders need to win the independent's vote to prevail on a contested matter.
Founders should track this carefully across rounds. A founder who still holds 30% of the company but has lost board majority can be removed as CEO by their own board — and many have been.
Protective provisions are the list of company actions that require approval by the preferred shareholders (typically a majority of the relevant series). The standard list is reasonable: investors want a veto on actions that could destroy or fundamentally change their investment, like selling the company, issuing new shares senior to theirs, or filing for bankruptcy. Expansive lists are not reasonable — terms that require investor consent to hire executives, change product strategy, enter new markets, or set the CEO's compensation give investors a degree of operational control that approaches employee management. Founders should push back on protective provisions that go beyond protecting the investor's economic interest.
Drag-along rights allow a defined majority of shareholders to force all other shareholders to participate in a sale of the company. This sounds anti-founder but is mostly necessary — an acquirer typically requires 100% of the equity to close a deal, and without drag rights, a few small holdouts could block a sale that the rest of the cap table supports. The negotiation is about what threshold triggers the drag (majority of preferred? majority of all shareholders? majority of common?) and whether founders are protected from being dragged into a sale at a price below a certain threshold.
Even when founders own their shares from day one, a venture investor will typically require those shares to vest over 4 years with a 1-year cliff. The investor's logic: if a founder leaves in year 2, the remaining founders shouldn't be stuck with a non-active person holding a large equity stake. Founders typically resist this at first and then accept it as reasonable. The negotiation is usually about acceleration: what happens if the founder is fired without cause (single-trigger acceleration: shares vest immediately) or what happens if the company is acquired (double-trigger acceleration: shares vest if the founder is fired within X months of the acquisition).
Investors with material stakes typically receive monthly financial reports (P&L, balance sheet, cash flow) during the early years, transitioning to quarterly later. They also receive annual audited financial statements and have inspection rights (the right to audit the books, with reasonable notice). These rights are generally reasonable for material shareholders. They do impose a real operational burden on the company — finance teams need to produce these reports — which is a hidden cost of taking institutional investment.
If a founder wants to sell shares (in a secondary transaction, for example), existing preferred investors typically have right of first refusal — the option to buy the shares themselves at the same price — and a co-sale right — the option to participate proportionally in the sale at the same price. The structure prevents founders from selling out separately while leaving the investors holding the bag. The constraint is usually accepted as reasonable, though it does mean founders can't easily monetize their shares before exit.
Most preferred stock includes a stated dividend rate (often 8%) that doesn't actually require the company to pay dividends — most venture-backed companies never pay them. The dividend right matters mostly in two places: (1) cumulative dividends accrue even if unpaid, increasing the liquidation preference over time; (2) some late-stage rounds include "PIK" (paid-in-kind) dividends that compound the investor's preference, which can substantially increase what they take home at exit. Standard practice is non-cumulative dividends, which mostly means the term is benign.
For decades, every venture firm had its own term-sheet template, slightly different from every other firm's. Founders raising their first round had to negotiate every clause from scratch, often without the experience to know which clauses mattered. The variation made the process slow, expensive in legal fees, and uneven in outcomes.
The National Venture Capital Association (NVCA), the U.S. industry association, addressed this by publishing a set of model documents — a Term Sheet, Stock Purchase Agreement, Investor Rights Agreement, Voting Agreement, and Right of First Refusal & Co-Sale Agreement — that represent the industry's consensus on standard language for each provision. The NVCA model documents have become the U.S. industry default. Most venture firms now start from the NVCA template and modify it for their specific terms.
The benefits of this standardization are substantial. Founders raising in the U.S. can read a term sheet and know what most of the language means, because they've seen it before in other deals. Lawyers can produce financing documents faster and cheaper. Disputes over standard language are rare because the meaning of each clause is well-understood. The downside: standardization tends to lock in whatever the industry consensus was at a particular moment, which can be slow to update when conditions change.
The current industry-standard term sheet for an early-stage round looks roughly like this:
Deviations from this baseline are points to negotiate. A term sheet that follows the standard in every respect is described as "clean." A term sheet that adds participating preferred, expansive protective provisions, multiple board seats, or aggressive anti-dilution is "structured" — a polite industry word for "this has terms that benefit the investor beyond the standard."
The NVCA model has been exported globally, but it has not been adopted universally. Different ecosystems have evolved different conventions, and founders raising across geographies need to know what's standard in each.
The British Venture Capital Association (BVCA) publishes model documents that parallel the NVCA's. The substantive provisions are similar — 1× non-participating preferred, weighted-average anti-dilution, four-year founder vesting — but the legal structure differs because UK company law differs from Delaware corporate law. The most notable differences for founders: UK term sheets typically use a single "Shareholders' Agreement" rather than the U.S. four-document structure; UK companies use share classes (Ordinary, A-Ordinary, Preferred) that map to common and preferred but with different terminology; and UK convertible-instrument practice differs from U.S. SAFEs (Module 06 will cover).
The European Venture Capital Association (formerly EVCA, now Invest Europe) publishes guidelines but each country's term-sheet practice is shaped by local company law. French SAS or SARL structures, German GmbH conventions, and Dutch BV practice all differ in ways that matter. Pan-European venture firms (Index, Atomico, Northzone) typically use modified NVCA-style documents adapted for the company's local jurisdiction.
Indian venture has converged toward NVCA-style term sheets for dollar-fund-led rounds, since the U.S. firms that dominate Indian Series A and later expect to work with familiar documents. Local seed rounds (rupee-denominated) often use simpler structures with less elaborate term sheets. The key local variation: Indian companies often have a layer of "founder shares" with special voting rights — partly a response to founder concerns about losing control in an ecosystem where investor-friendly behavior was once more common than it is now.
Chinese venture historically used a parallel structure that resembled but did not match U.S. conventions, partly because Chinese securities and corporate law differ substantially from Delaware. U.S.-related Chinese venture (deals targeting eventual U.S. IPO via VIE structures) used NVCA-style documents adapted to the cross-border structure. Post-2021 regulatory changes have largely shut down the U.S.-IPO path, which has reshaped Chinese term-sheet conventions toward purely domestic structures. The full effect of the shift is still settling.
Term-sheet conventions are not static. They shift with market conditions, and the 2021-2023 cycle was one of the most consequential periods of change in recent venture history. Understanding what happened is useful both as history and as warning about how quickly norms can move.
Between mid-2020 and late 2021, with low interest rates and abundant capital, venture pricing rose to historic highs and terms became progressively more founder-friendly. Common features of the period: clean 1× non-participating preferred became universal; protective provisions narrowed; "no-board-seat" deals became common at growth stages; valuation caps on SAFEs (Module 06) loosened or disappeared; investor diligence shortened from weeks to days; pro-rata rights and even basic information rights were sometimes dropped to win competitive deals. Tiger Global's strategy of writing extremely fast checks at high valuations with minimal terms set the pace for much of the market.
The funding-environment shift in 2022 — rising interest rates, public-market multiple compression, the SVB collapse in March 2023 — produced a sharp reversal. Investors regained leverage, and term sheets at every stage moved back toward investor protection. Common features of the period: participating preferred returned in many late-stage deals; multiple liquidation preferences appeared in distressed rounds; full ratchet anti-dilution showed up in down rounds where founders had no leverage; expansive protective provisions returned; board seats expanded; expanded diligence requirements added weeks to closing timelines.
Founders who had taken structured terms in earlier rounds (when the market was hot and the structures seemed manageable) faced compounding effects in down rounds (when the same structures became punitive).
By 2024, the market had stabilized into a middle position: roughly 1× non-participating at early stages, with structure returning at late stages where investors had more leverage. Diligence timelines returned to historical norms (4-8 weeks). Pro-rata and information rights were restored. The 2021-era extremes of either founder-friendly looseness or 2022-era investor-friendly tightness gave way to more conventional terms.
The longer lesson from the cycle: terms are negotiated in the context of the market at the moment, and what was standard in one period may be aggressive or generous in another. Founders raising at any given moment should benchmark against the current standard, not against a prior period's norms. Investors offering a particular term sheet should be prepared to defend it as reasonable in the current market.
To make the material in this module concrete, here is a simulated term sheet for the Pipework Series A from our running example (Modules 02 and 03). Each clause is shown in the standard term-sheet language, followed by commentary on what it means and what to watch for.
This is a "clean" term sheet — standard 1× non-participating, weighted-average anti-dilution, standard option-pool sizing, balanced board, standard protective provisions, double-trigger founder vesting, standard pro-rata. Compared to the 2022-23 cycle's more structured deals, it's founder-friendly. Compared to the 2021 peak, it's mildly investor-friendly. It's the middle of the road by 2026 standards — exactly what a Pipework-stage Series A should look like.
Six questions on preferred-stock mechanics, the structure of a term sheet, and the difference between economic and control terms.